FRESENIUS MEDICAL CARE AG Miscellaneous Other Operating Expense
FRESENIUS MEDICAL CARE AG (FMS) reported Miscellaneous Other Operating Expense of EUR 102.30 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-24.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:MiscellaneousOtherOperatingExpense · last filed 2026-02-24
- FRESENIUS MEDICAL CARE AG miscellaneous other operating expense for the quarter ending 2025-12-31 was 36.56M EUR, a 5.13% increase year-over-year.
- FRESENIUS MEDICAL CARE AG miscellaneous other operating expense for the quarter ending 2025-09-30 was 13.86M EUR, a 60.93% decline year-over-year.
- FRESENIUS MEDICAL CARE AG miscellaneous other operating expense for the quarter ending 2025-06-30 was 20.32M EUR, a 70.32% increase year-over-year.
- FRESENIUS MEDICAL CARE AG miscellaneous other operating expense for the quarter ending 2025-03-31 was 31.57M EUR, a 65.26% increase year-over-year.
| Period end | Miscellaneous Other Operating Expense 3 month | Miscellaneous Other Operating Expense 3 month as first filed | Miscellaneous Other Operating Expense 6 month | Miscellaneous Other Operating Expense 9 month | Miscellaneous Other Operating Expense 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | 36.56M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-24 | 50.42M EUR derived: sum of 2 quarters · filed 2026-02-24 | 70.74M EUR derived: sum of 3 quarters · filed 2026-02-24 | 102.30M EUR 20-F · filed 2026-02-24 | |
| 2025-09-30 | 13.86M EUR 6-K · filed 2025-11-04 | 34.18M EUR derived: sum of 2 quarters · filed 2025-11-04 | 65.75M EUR 6-K · filed 2025-11-04 | 100.52M EUR derived: sum of 4 quarters · filed 2026-02-24 | |
| 2025-06-30 | 20.32M EUR 6-K · filed 2025-08-05 | 51.88M EUR 6-K · filed 2025-08-05 | 86.66M EUR derived: sum of 3 quarters · filed 2026-02-24 | 122.14M EUR derived: sum of 4 quarters · filed 2026-02-24 | |
| 2025-03-31 | 31.57M EUR 6-K · filed 2025-05-06 | 66.34M EUR derived: sum of 2 quarters · filed 2026-02-24 | 101.82M EUR derived: sum of 3 quarters · filed 2026-02-24 | 113.75M EUR derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-12-31 | 34.77M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-24 | 70.26M EUR derived: sum of 2 quarters · filed 2026-02-24 | 82.19M EUR derived: sum of 3 quarters · filed 2026-02-24 | 101.28M EUR 20-F · filed 2026-02-24 | |
| 2024-09-30 | 35.48M EUR 6-K · filed 2025-11-04 | 47.41M EUR derived: sum of 2 quarters · filed 2025-11-04 | 66.51M EUR 6-K · filed 2025-11-04 | 88.58M EUR derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-06-30 | 11.93M EUR 6-K · filed 2025-08-05 | 31.03M EUR 6-K · filed 2025-08-05 | 53.09M EUR derived: sum of 3 quarters · filed 2026-02-24 | 90.65M EUR derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-03-31 | 19.10M EUR 6-K · filed 2025-05-06 | 41.17M EUR derived: sum of 2 quarters · filed 2026-02-24 | 78.72M EUR derived: sum of 3 quarters · filed 2026-02-24 | 100.83M EUR derived: sum of 4 quarters · filed 2026-02-24 | |
| 2023-12-31 | 22.07M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-24 | 59.62M EUR derived: sum of 2 quarters · filed 2026-02-24 | 81.73M EUR derived: sum of 3 quarters · filed 2026-02-24 | 98.63M EUR 20-F · filed 2026-02-24 | |
| 2023-09-30 | 37.55M EUR 6-K · filed 2024-11-05 | 59.66M EUR derived: sum of 2 quarters · filed 2024-11-05 | 76.56M EUR 6-K · filed 2024-11-05 | 118.30M EUR derived: sum of 4 quarters · filed 2025-02-25 | |
| 2023-06-30 | 22.11M EUR 6-K · filed 2024-07-30 | 39.01M EUR 6-K · filed 2024-07-30 | 80.74M EUR derived: sum of 3 quarters · filed 2025-02-25 | 122.21M EUR derived: sum of 4 quarters · filed 2025-02-25 | |
| 2023-03-31 | 16.89M EUR 6-K · filed 2024-05-07 | 100.33M EUR 6-K · filed 2023-05-09 | 58.63M EUR derived: sum of 2 quarters · filed 2025-02-25 | 100.10M EUR derived: sum of 3 quarters · filed 2025-02-25 | 131.77M EUR derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | 41.74M EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-02-25 | 83.20M EUR derived: sum of 2 quarters · filed 2025-02-25 | 114.87M EUR derived: sum of 3 quarters · filed 2025-02-25 | 125.56M EUR 20-F · filed 2025-02-25 | |
| 2022-09-30 | 41.46M EUR 6-K · filed 2023-11-02 | 73.13M EUR derived: sum of 2 quarters · filed 2023-11-02 | 83.82M EUR 6-K · filed 2023-11-02 | ||
| 2022-06-30 | 31.67M EUR 6-K · filed 2023-08-02 | 42.36M EUR 6-K · filed 2023-08-02 | |||
| 2022-03-31 | 14.14M EUR 6-K · filed 2023-05-09 | ||||
| 2021-12-31 | 53.35M EUR 20-F · filed 2024-02-20 |